Gordon, K.; Thaçi, D.; Gooderham, M.; Okubo, Y.; Strober, B.; Peterson, L.; Deherder, D.; López Pinto, J.; Gisondi, P. Bimekizumab Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Pooled Analysis from Up to 4 Years of Treatment in 5 Phase 3/3b Clinical Trials. J of Skin 2024, 8, s404.